Operadora Unidad de Investigación en Salud de Chihuahua S.A. de C.V.

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine	Headache, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms	Active, not recruiting	Phase 3	2026-02-27		NCT04616326
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine	Headache, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms	Active, not recruiting	Phase 3	2026-01-26		NCT03432286

Clinical trials